C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/1992
11/23/1992	CA2063055A1 Peptides having thrombospondin-like activity and their therapeutic use
11/19/1992	EP0514361A1 Galanin antagonist
11/19/1992	EP0514210A2 GRF analogs
11/19/1992	EP0513613A1 Novel polypeptides with affinity to lipopolysaccharides and their uses
11/18/1992	CN1066272A Process for preparation of anti-thrombin polypeptides
11/17/1992	US5164481 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
11/17/1992	US5164369 Asparagine, leucine, arginine, cysteine
11/17/1992	US5164366 Diabetes
11/17/1992	CA1310444C Cck8 derived peptides, their preparation, and pharmaceutical compositions containing them
11/15/1992	WO1992020708A1 Peptide inhibitors of inflammation
11/15/1992	CA2103139A1 Peptide inhibitors of inflammation
11/12/1992	WO1992019746A1 Recombinant immunocastration vaccine and polypeptides useful for same
11/12/1992	WO1992019651A1 Luteinizing hormone releasing hormone antagonist peptides
11/12/1992	WO1992019646A1 Analog of endothelial leukocyte adhesion molecule (elam)
11/12/1992	WO1992019645A1 A novel polypeptide with affinity to lipopolysaccharides and their uses
11/12/1992	WO1992019644A1 Vasorelaxant peptide
11/12/1992	WO1992019643A1 Method for synthesizing peptides, novel amino acid derivatives used therein, and methods for preparing same
11/12/1992	WO1992019257A1 Compositons for the treatment of chronic fatigue syndrome
11/12/1992	WO1992019253A1 CCK ANALOGS CONTAINING α-SUBSTITUTED AMINO ACIDS
11/12/1992	WO1992019248A1 High affinity mannose receptor ligands
11/12/1992	CA2109527A1 Amino-acid sequence homologies between selectins and b pertussis toxin-peptides derived therefrom, antibodies thereto and pharmaceutical compositions
11/12/1992	CA2106765A1 Cck analogs containing ó-substituted amino acids
11/11/1992	EP0512042A1 Glp-1 analogs useful for diabetes treatment
11/10/1992	WO1992019648A1 Wf11243 substance
11/10/1992	US5162500 Poststatin and related compounds or salts thereof
11/10/1992	US5162497 Bradykinin analogs with non-peptide bond
11/10/1992	US5162305 Polypeptide derivatives
11/10/1992	US5162211 Process for producing a cyclic lipopeptide employing zalerion arboricola
11/10/1992	CA2102705A1 Wf11243 substance
11/05/1992	DE4214328A1 New phosphinate-contg. peptide derivs. - as collagenase inhibitors e.g. for treating gangrene or dental infections
11/04/1992	EP0511866A2 Process for the crystallization of cyclic lipopeptides
11/04/1992	EP0511830A2 Affinity purified heparin
11/04/1992	EP0511816A2 Neurotrophic peptide derivative
11/04/1992	EP0511747A1 Hybrid polypeptide containing an avidin binding polypeptide
11/04/1992	EP0138854B1 Antigenically active amino acid sequences
11/04/1992	CN1065867A Peptides and mixtures thereof for detecting antibodies to hepatitis c virus
11/03/1992	CA1309671C Monoclonal antibodies to cyclosporins
11/02/1992	CA2067294A1 Process for crystalline cyclic lipopeptides
10/1992
10/29/1992	WO1992018627A1 Glial mitogenic factors, their preparation and use
10/29/1992	WO1992018536A2 Method for detecting an localizing tissues having neurokinine 1 receptors
10/29/1992	WO1992018534A1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
10/29/1992	WO1992018531A1 Growth hormone releasing factor analogs
10/29/1992	WO1992018530A1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN
10/29/1992	WO1992018529A1 Increasing blood-brain barrier permeability with permeabilizer peptides
10/29/1992	WO1992018528A1 Branched peptides in assays for antibodies
10/29/1992	WO1992018526A1 Production of phosphopeptides from casein
10/29/1992	WO1992018490A1 Novel dna gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same
10/29/1992	WO1992018149A1 Assay systems for neurotrophin activity
10/29/1992	WO1992018144A1 Substituted benzhydrylamines as handles for solid phase peptide synthesis
10/29/1992	WO1991018992A3 Methods to make and use proteinaceous material present in kinin-free high molecular weight kininogen
10/29/1992	CA2109100A1 Assay systems for neurotrophin activity
10/29/1992	CA2106874A1 Method for detecting and localizing tissues having neurokinine 1 receptors
10/29/1992	CA2084061A1 Growth hormone releasing factor analogs
10/28/1992	EP0511188A2 Novel binding peptides
10/28/1992	EP0510912A1 Antimicrobial peptide and antimicrobial agent
10/28/1992	EP0510132A1 Polymeric carriers for release of covalently linked agents.
10/28/1992	EP0510063A1 Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
10/28/1992	EP0441832A4 Composition and treatment with biologically active peptides and certain anions
10/28/1992	CN1065682A Trans-splicing ribozymes
10/28/1992	CN1065681A Cell ablation using trans-splicing ribozymes
10/28/1992	CA2067039A1 Neurotrophic peptide derivatives
10/27/1992	US5159061 Hypotensive agent, diuretic
10/27/1992	US5159059 Process for reduction of certain cyclohexapeptide compounds
10/27/1992	CA1309558C D-gl conjugate therapy
10/25/1992	WO1992019254A1 α-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
10/25/1992	CA2106764A1 Ó-substituted polypeptides having therapeutic activity
10/21/1992	EP0509080A1 Inhibitors and substrates of thrombin
10/21/1992	EP0508983A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
10/21/1992	EP0190205B1 Method for determining mimotopes
10/20/1992	WO1992018156A1 Bradykinin antagonist peptides
10/20/1992	WO1992018155A1 Bradykinin type peptides
10/20/1992	US5157020 Two covalently bonded peptides
10/20/1992	US5156960 Microbial process for the production of immunosuppressive antibiotics
10/20/1992	CA2064933A1 Carrier protein
10/20/1992	CA2040849A1 Method for detection of human papillomavirus (hpv) for diagnostic purposes
10/20/1992	CA1309019C Combinations having synergistic growth hormone releasing activity and methods for use thereof
10/17/1992	WO1992018513A1 New non-hygroscopic mono-ammonium salts
10/16/1992	WO1992018146A1 Novel biologically active peptide compositions and uses therefor
10/16/1992	CA2083594A1 Biologically active peptide compositions and uses therefor
10/15/1992	WO1992017788A1 Ionic reservoir at electrode surface
10/15/1992	WO1992017602A1 Parathyroid hormone receptor and dna encoding same
10/15/1992	WO1992017493A2 Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
10/15/1992	WO1992017201A1 Bradykinin antagonists
10/15/1992	WO1992017197A1 Novel peptide compositions and uses therefor
10/15/1992	CA2106677A1 Bradykinin antagonists
10/14/1992	EP0507968A1 Method for the fermentative production and isolation of cyclosporin A and new cyclosporin forming strains
10/13/1992	US5155210 Produce localized cytotoxic effects on target cells; antitumor and anticarcinogenic agents
10/13/1992	US5155209 Anticarcinogenic, antitumor agents
10/13/1992	US5155041 Culture of Bacillus subtilis
10/13/1992	US5154923 Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions
10/09/1992	WO1992017195A1 Novel peptide compositions and uses therefor
10/09/1992	CA2107674A1 Novel peptide compositions and uses therefor
10/07/1992	EP0507615A1 Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
10/07/1992	EP0506820A1 Neutrophil chemoattractants
10/06/1992	WO1992017492A1 PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIII¿a?
10/06/1992	US5153175 Method of inducing sleep with GHRH complementary peptide compositions
10/06/1992	CA2106314A1 Platelet aggregation inhibitors having high specification for gpiibiiia
10/06/1992	CA1308515C Peptide derivatives and processes for their preparation
10/01/1992	WO1992017025A2 GnRH ANALOGS
10/01/1992	WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor

1 ... 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 ... 423